Drug makers may profit from disease in global warming scourge

authordefault
on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on

Internal documents unearthed by a U.S. Senate panel show the oil giant modeled up to 500 CCS sites operating globally by 2050, far fewer than rival Shell. 

Internal documents unearthed by a U.S. Senate panel show the oil giant modeled up to 500 CCS sites operating globally by 2050, far fewer than rival Shell. 
on

But demand for hydrogen-powered vehicles remains low, and claims the gas is a net-zero technology are still unproven.

But demand for hydrogen-powered vehicles remains low, and claims the gas is a net-zero technology are still unproven.
on

The Conservative leader voted in favour of protecting the planet only 13 times in 20 years as an MP, a DeSmog analysis of his voting record reveals.

The Conservative leader voted in favour of protecting the planet only 13 times in 20 years as an MP, a DeSmog analysis of his voting record reveals.

Campaigners likened the fossil fuel company’s patronage of climate events to letting an “arsonist sponsor a fire safety conference”.

Campaigners likened the fossil fuel company’s patronage of climate events to letting an “arsonist sponsor a fire safety conference”.